INVESTOR ALERT: Hagens Berman Alerts Investors in Seres Therapeutics, Inc. (NASDAQ: MCRB) to Investigation into Possible Securities Law Violations

or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing MCRB@hbsslaw.com.
(Orginal – Story lesen…)

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
792